Cargando…
C1-inhibitor concentrate home therapy for hereditary angioedema: a viable, effective treatment option
Economic and political factors have led to the increased use of home therapy programmes for patients who have traditionally been treated in hospital. Many patients with hereditary angioedema (HAE) experience intermittent severe attacks that affect their quality of life and may be life-threatening. T...
Autores principales: | Longhurst, H J, Carr, S, Khair, K |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Blackwell Science Inc
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1804208/ https://www.ncbi.nlm.nih.gov/pubmed/17177958 http://dx.doi.org/10.1111/j.1365-2249.2006.03256.x |
Ejemplares similares
-
Hereditary angioedema with C1 inhibitor deficiency: delay in diagnosis in Europe
por: Zanichelli, Andrea, et al.
Publicado: (2013) -
Phase II study results of a replacement therapy for hereditary angioedema with subcutaneous C1‐inhibitor concentrate
por: Zuraw, B. L., et al.
Publicado: (2015) -
Treatment of hereditary angioedema—single or multiple pathways to the rescue
por: Valerieva, Anna, et al.
Publicado: (2022) -
Exposure‐Response Model of Subcutaneous C1‐Inhibitor Concentrate to Estimate the Risk of Attacks in Patients With Hereditary Angioedema
por: Zhang, Ying, et al.
Publicado: (2018) -
Optimum Use of Acute Treatments for Hereditary Angioedema: Evidence-Based Expert Consensus
por: Longhurst, Hilary
Publicado: (2018)